Register for an all-star cast roundtable discussion Developing an effective #HIV vaccine: what do we need and when will we get there? First attempts to develop a vaccine against HIV started in the 1980s. Thirty y..
EAVI2020 was well represented at Cent Gardes Symposium. Organised by the Mérieux Foundation, the forum of international experts took place from 30 September to 2 October in France. Partners, Imperial College London, C..
Click to download the newsletter (opens in a new window)
It’s time to take a look at one of EAVI2020’s partners, Fundació Privada Institut de Recerca de la Sida-Caixa (IrsiCaixa) situated in Barcelona, Spain. We had a quick chat with Dr Christian Brander leading the rese..
EAVI2020 coordinator, Prof Robin Shattock lead the recent Imperial Global Science Policy Forum which focussed on global challenges surrounding vaccines and the latest research in vaccine technology. EAVI coordinator,..
The EAVI2020 Newsletter May 2019 is here! This issue features the start of clinical trials for HIV vaccine as well as the 7th PhD Training Course in Vienna.
Dr. Joan Joseph from Fundació Privada Clínic per a la Recerca Biomèdica (FCRB) and Prof. Brita Wahren from the Karolinska Institutet have recently returned from the hugely successful 7th PhD training course, “From L..
The European AIDS Vaccine Initiative (EAVI2020) are getting closer to developing a protective vaccine against HIV with clinical trials now underway. Researchers are excited to announce they have started clinical ..
The EAVI2020 Newsletter February 2019 is here! This month’s newsletter features our project Partner IAVI-HIL as well as the 7th PhD Training Course and upcoming events.
A TRANSVAC Workshop entitled 'In vivo imaging of host response to vaccines and infections' will be taking place in Fontenay-aux-Roses, France on the 29th March 2019. Led by our Partner institution CEA, the aim of th..
The EAVI2020 Newsletter November 2018 is here! This month’s newsletter provides insight into our 3rd Annual Meeting, including the 6th PhD Training Course, as well as highlights from HIVR4P and the EAVI2020 Photo Ex..
Our Consortium members are delighted to have been given the opportunity to host a Satellite Session at this year’s HIVR4P Conference taking place in Madrid, Spain. This is a prestigious event which attracts internati..
‘The Development of an HIV Vaccine in Photos’ was most recently held at INSERM and has now moved to another one of our project Partners CEA also based in Paris, France. The exhibition is on display in the cafeteri..
The EAVI2020 Newsletter August 2018 is here! This month’s newsletter provides exciting updates of our EAVI2020’s Prof. Stephen Kent who embarked on his European tour, a feature on our project Partner Karolinska Ins..
EAVI2020 Partner Focused Story: Karolinska Institutet Situated centrally in Stockholm, Karolinska Institutet (KI) has been committed to medical research and education for over 200 years. Immunology has always been a ..
St Mary's Hospital, Imperial College London Established in 1853, the University of Melbourne (UOM) is an internationally recognised institution that makes distinctive contributions to society in research, learning and t..
The EAVI2020 Newsletter May 2018 is here! This month’s newsletter provides exciting updates of our EAVI2020’s Photo Exhibition which is on display in Paris, our project Partner AMC and highlights from pas..
After the success of 'The Development of an HIV Vaccine in Photos' exhibition held in Hospital Clínic, Barcelona, we're thrilled to announce that the exhibition will now be displayed by our Partner institute INSERM (CIM..
EAVI2020 is a collaborative research project that aims to accelerate the identification and development of an effective HIV vaccine that may have utility both to prevent infection and contribute to the establishment of..
Professor Rogier Sanders (Principal Investigator) and Assistant Professor Marit van Gils of Academisch Medisch Centrum (AMC) were recently featured in a children’s program broadcast on Dutch national television. “De ..
The February 2018 EAVI2020 Newsletter is here! This month’s newsletter provides an exciting insight in to EAVI2020’s publications for 2017, our project Partner Polymun and highlights from past and upcoming events.
Founded 1992, Polymun is a private company fully owned by the Katinger family, located in Klosterneuburg. The company offers development and GMP (Good Manufacturing Practice) production of biopharmaceuticals and liposoma..
Following on from the success of EAVI20202’s Photo Exhibition launch which was held at Bacanal Café, Barcelona on the 7th November 2017, we have created a brochure that is now available to the general public. The..
The November 2017 EAVI2020 Newsletter is here! To mark World AIDS Day, this new edition features discussions from our Year 2 Consortium Annual Meeting, the 4th PhD course on HIV immunology and vaccines and a special ..
Taking the opportunity that all the partner institutions will be in Barcelona for the project’s annual meeting, EAVI2020 has organised a photo exhibition on The development of an HIV vaccine in Barcelona, 7th N..
EAVI2020’s partner institutions presented the latest research on HIV vaccines at the 9th IAS Conference on HIV Science. The Conference The IAS Conference on HIV Science is the largest open scientific conference on..
The eAccess Meetings project In 2016, The Global HIV Vaccine Enterprise and Keystone Symposia inaugurated a collaboration to produce an ePanel discussion and series of SciTalks presentations that brought together k..
The June 2017 EAVI2020 Newsletter is here! This new edition features our Third PhD course on HIV immunology and vaccines, which took place on 23-26 April 2017 in Stockholm. Find out about the exciting topics that ..
On 23-26 April 2017, EAVI2020 celebrated its Third PhD course on HIV immunology and vaccines. The course was organised by project partners Karolinska Institutet and Fundació Clinic per a la Recerca Biomèdica and to..
EAVI2020’s partner institutions presented the latest research on HIV vaccines at the Keystone Symposia on HIV vaccines. As part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gate..
The Beijerinck Premium is intended to encourage virology research and is awarded every two years. Marit van Gils is a post-doc researcher at Academisch Medisch Centrum and is part of the team working in EAVI2020. This..
We are excited to present the fifth issue of the EAVI2020 Newsletter! In this issue you will find out about: EAVI2020's published papers on year 1 Links to talks by EAVI2020 at the 2016 Keystone Symposia on H..
The Global HIV Vaccine Enterprise in collaboration with Keystone Symposia organized an ePanel discussion and series of SciTalks presentations that brought together key experts in the HIV prevention vaccine field. The ..
Prof Robin Shattock (Imperial) presented at the plenary session of the Spanish AIDS society (GESIDA)' s AIDS Research Network (RIS) annual meeting in San Sebastian, Spain, 30th November 2016. Prof Shattock was also i..
Fundació Clínic per a la Recerca Biomèdica and Karolinska Institutet organised the Second course on HIV immunology and vaccines in Barcelona, 9th November 2016. Twenty four students from all over Europe joined th..
17-21 November 2016 Dr Joan Joseph from Fundació Clínic per a la Recerca Biomèdica presented lessons learned on "Pre-clinical development of recombinant BCG based HIV vaccine" at the event, which took place at th..
Coinciding with the project’s one year anniversary, we are excited to publish the fourth issue of the EAVI2020 Newsletter! In this issue we have covered our upcoming EAVI2020 first annual meeting and 2nd PhD course..
The Center for Immunology and Microbial Infection (CIMI-Paris) is a research unit of Inserm - Institut National de Santé et de Recherche Médicale (French National Institutes of Health). At CIMI-Paris and within the ..
EAVI2020’s partner institutions will be at the HIVR4P Conference in Chicago this week. HIV Research for Prevention 2016: AIDS Vaccine, Microbicide, and ARV-based Prevention Science (HIVR4P 2016) will be held 17–21..
Marit van Gils, who is part of the Academisch Medisch Centrum's team involved in EAVI2020, has been selected as one of eight New Investigator Award recipients of the HIV Research for Prevention 2016: AIDS Vaccine, Microb..
Prof José (Pepe) Alcami is the director of the AIDS Immunopathogenesis Unit at Instituto de Salud Carlos III and Coordinator of the Spanish AIDS Research Network (RIS). The AIDS Immunopathogenesis Unit The AIDS Im..
Prof Quentin Sattentau’s lab is one of the groups at the University of Oxford working on the EAVI2020 project. Their work focuses on the function of HIV-1 Env and HIV-1 neutralizing antibodies. Background on the fun..
The 8th edition of the ICAR (Italian Conference on AIDS and Antiviral Research) will be held in Milan, at University of Milano-Bicocca, from June 6-8, 2016. EAVI2020 partner Ospedale San Raffaele (OSR) will present a ..
The May issue of the EAVI2020 Newsletter has been published! In this issue we have covered the most recent project events and news. You can also find links to international press articles about EAVI2020 and a list ..
As part of the EAVI2020 Continuing Education and Training in an HIV vaccine development Programme, project partners Fundació Clinic per a la Recerca Biomèdica and Karolinska Institutet have organized the first training..
The first EAVI2020 Newsletter was recently launched! This issue of the project's Newsletter features three short articles on the first activities of the project since its kick-off date on 1st November 2015. It..
The Neutralizing Antibody Consortium (NAC) held its Annual meeting in La Jolla, California, on the 16th to 18th February 2016. The NAC was launched by EAVI2020’s project partner IAVI in 2002 to solve a fundamental p..
Imperial College hosted EAVI2020 's kick-off meeting in London on Thursday 26th November 2015. Representatives from the project’s partner institutions travelled to London to attend the kick-off meeting of this excit..
In response to circa 2 billion euros of Health and ICT innovation-based funding about to be launched by the European Commission, Vision 2020: The Horizon Network hosted London's Horizon 2020 Health-Tech event on 29 and 3..
A new 23 million euro initiative to accelerate the search for an effective HIV vaccine begins today. Financed by the European Commission, the European AIDS Vaccine Initiative (EAVI2020) brings together leading HIV res..
